ChaitraShankarUjjaniMD

PubMed

• 6 citations
  Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.
  Sarah C Rutherford, Jun Yin, Levi Pederson, Gabriela Perez Burbano, Betsy LaPlant
  Journal of Clinical Oncology. 2023-01-10
• 49 citations
  Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103.
  Chaitra S. Ujjani, Sin-Ho Jung, Brandelyn N. Pitcher, Peter Martin, Steven I. Park
  Blood. 2015-12-03
• 313 citations
  Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis
  Anthony R. Mato, Chadhi Nabhan, Meghan C. Thompson, Nicole Lamanna, Danielle M. Brander
  Haematologica. 2018-05-01

Journal Articles

• Real World Outcomes and Management Strategies for Venetoclax-Treated Chronic Lymphocytic Leukemia Patients in the United States  
  Arun K Singavi, Andrew Zelenetz, Nicole Lamanna, Bruce D Cheson, Richard R Furman, Jakub Svoboda, Stephen J Schuster, John N Allan, Chaitra S Ujjani, Haematologica

Abstracts/Posters

• High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical Outcomes
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact of Lab Abnormalities at the Time of Progression in Patients Receiving CD19-Specific CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Treatment Sequences and Outcomes of Patients with CLL Treated with Venetoclax and Other Novel Agents Post Introduction of Novel Therapies
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Veneto-STOP Study: Sequential Assessment of Minimal Residual Disease By Next Generation Sequencing to Optimize Outcomes and Minimize Exposure in Venetoclax-Treated CLL...
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies
  Chaitra Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Treatment Sequences and Outcomes of Patients with CLL Treated with Venetoclax and Other Novel Agents Post Introduction of Novel Therapies
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Veneto-STOP Study: Sequential Assessment of Minimal Residual Disease By Next Generation Sequencing to Optimize Outcomes and Minimize Exposure in Venetoclax-Treated CLL... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019